Quantumleap Healthcare Collaborative
Clinical trials sponsored by Quantumleap Healthcare Collaborative, explained in plain language.
-
Can a platform trial match the right drug combo to each tumor?
Disease control Recruiting nowThis phase I/II platform trial tests several drug combinations, including evorpacept, trastuzumab deruxtecan, zanidatamab, tucatinib, and TTX-MC138, in people with advanced solid tumors, especially metastatic breast cancer. The goal is to find safe and promising regimens that cou…
Phase 1/2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could hormone pills replace surgery for some early breast cancers?
Disease control Recruiting nowThis study tests whether active surveillance (close monitoring) combined with hormonal therapy can safely manage ductal carcinoma in situ (DCIS), a very early form of breast cancer. About 400 women with hormone-positive DCIS will receive either standard or investigational hormone…
Phase 2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Breast cancer trial aims to match drugs to tumors for personalized care
Knowledge-focused Recruiting nowThis study is testing new drug combinations for breast cancer to see which ones work best for different tumor types. It involves up to 5,000 people with early-stage or locally advanced breast cancer. Researchers use MRI scans and tissue samples before surgery to predict treatment…
Phase 2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC